Bone Biologics Corporation
BBLG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9 | $7 | $7 | $109 |
| - Cash | $3 | $3 | $8 | $7 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $5 | $4 | -$0 | $102 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | $0 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$9 | -$1 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.83 | -34.01 | -31.2 | -37.35 |
| % Growth | 85.8% | -9% | 16.5% | – |
| Operating Cash Flow | -$4 | -$10 | -$4 | -$1 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$4 | -$10 | -$4 | -$1 |